Michael Joseph Golembiewski's Net Worth
-$108 Thousand
Who is Michael Joseph Golembiewski?
Michael Joseph Golembiewski does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SEELOS THERAPEUTICS, INC., and PERNIX THERAPEUTICS HOLDINGS, INC..
SEC CIK
Michael Joseph Golembiewski's CIK is 0001639479
Past Insider Trading and Trends
2023 was Michael Joseph Golembiewski's most active year for acquiring shares with 5 total transactions. Michael Joseph Golembiewski's most active month to acquire stocks was the month of January. 2023 saw Michael Joseph Golembiewski paying a total of $116,347.50 for 873,731 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEELOS THERAPEUTICS, INC. (SEEL) Snapshot price: $0.2305
Chief Financial OfficerMichael Joseph Golembiewski owns 86,869 units of Common Stock which is worth $20,023.30. From 2021 to 2024 Michael Joseph Golembiewski acquired a total of 120,917 shares in SEELOS THERAPEUTICS, INC. at a cost of $128,067.45.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.48% | 417 |
$1.10 | $457.45 | 86.87K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| +2,405.80% | 83K |
$1.21 | $100,222.50 | 86.45K |
Nov 30
| |||
Form 4
| +13.74% | 12.5K |
$0.62 | $7,725.00 | 103.49K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +15.93% | 12.5K |
$0.67 | $8,400.00 | 90.99K |
Feb 28
| |||
Form 4
| +18.94% | 12.5K |
$0.90 | $11,262.50 | 78.49K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERNIX THERAPEUTICS HOLDINGS, INC. No price found
VP Finance, Controller, CAOMichael Joseph Golembiewski owns 3,300 units of Common Stock. In the year 2015 Michael Joseph Golembiewski acquired a total of 3,300 shares in PERNIX THERAPEUTICS HOLDINGS, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.3K |
—
|
—
| 3.3K |
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||